Back to top

Image: Bigstock

Company News for Apr 21, 2020

Read MoreHide Full Article
  • Shares of Cyclacel Pharmaceuticals, Inc. (CYCC - Free Report) surged 34.8% after the company announced a collaboration agreement with the University of Edinburgh to study its CDK Inhibitors to diminish runaway inflammation in COVID-19.
  • Shares of NovaBay Pharmaceuticals, Inc. (NBY - Free Report) soared 69.7% after the company signed an agreement to distribute coronavirus antibody rapid point-of-care test to U.S. healthcare professionals.
  • Shares of Exelixis, Inc. (EXEL - Free Report) rose 21.3% after the company announced the results from its Phase 3 CheckMate-9ER Trial, which met the primary endpoint.
  • Shares of Co-Diagnostics, Inc. (CODX - Free Report) gained 11.4% after the company said its COVID-19 test orders in the United States have continued to rise.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Exelixis, Inc. (EXEL) - free report >>

Cyclacel Pharmaceuticals, Inc. (CYCC) - free report >>

NovaBay Pharmaceuticals, Inc. (NBY) - free report >>

Co-Diagnostics, Inc. (CODX) - free report >>

Published in

medical